exploit to drive

In this study we performed a systematic search to identify breast cancer-specific small non-coding RNAs, which we have collectively termed orphan non-coding RNAs (oncRNAs). We subsequently discovered that one of these oncRNAs, which originates from the 3’ end of TERC, acts as a regulator of gene expression and is a robust promoter of breast cancer metastasis. This oncRNA, which we have named T3p, exerts its pro-metastatic effects by acting as an inhibitor of RISC complex activity and increasing the expression of the pro-metastatic genes NUPR1 and PANX2. Furthermore, we have shown that oncRNAs are present in cancer cell-derived extracellular vesicles, raising the possibility that these circulating oncRNAs may also play a role in non-cell

[1]  Frank McCormick,et al.  RAS Proteins and Their Regulators in Human Disease , 2017, Cell.

[2]  Kyowon Jeong,et al.  Genome-wide Mapping of DROSHA Cleavage Sites on Primary MicroRNAs and Noncanonical Substrates. , 2017, Molecular cell.

[3]  Xuemei Lu,et al.  The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process. , 2016, Annual review of genetics.

[4]  S. Johansen,et al.  Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines , 2016, PloS one.

[5]  Henrik Molina,et al.  Modulated Expression of Specific tRNAs Drives Gene Expression and Cancer Progression , 2016, Cell.

[6]  Gene W. Yeo,et al.  Robust transcriptome-wide discovery of RNA binding protein binding sites with enhanced CLIP (eCLIP) , 2016, Nature Methods.

[7]  S. Tavazoie,et al.  Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts , 2016, Genes & development.

[8]  Lisa Fish,et al.  Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement , 2015, Cell.

[9]  Boqin Hu,et al.  CLIPdb: a CLIP-seq database for protein-RNA interactions , 2015, BMC Genomics.

[10]  S. Tavazoie,et al.  Extracellular Metabolic Energetics Can Promote Cancer Progression , 2015, Cell.

[11]  Yi-Ching Wang,et al.  Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer , 2014, Cell & Bioscience.

[12]  Saeed Tavazoie,et al.  Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins , 2014, Nature.

[13]  A. Mele,et al.  Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer , 2014, eLife.

[14]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[15]  A. Mele,et al.  Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis , 2014, Nature Protocols.

[16]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[17]  Michael Golatta,et al.  Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer , 2013, PloS one.

[18]  Supriyo De,et al.  Age-related changes in microRNA levels in serum , 2013, Aging.

[19]  Brendan J. Frey,et al.  A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.

[20]  D. Tollervey,et al.  Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.

[21]  R. Bak,et al.  Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. , 2013, RNA.

[22]  J. Lingner,et al.  AUF1/HnRNP D RNA binding protein functions in telomere maintenance. , 2012, Molecular cell.

[23]  Gabriele Varani,et al.  Faculty Opinions recommendation of Systematic discovery of structural elements governing stability of mammalian messenger RNAs. , 2012 .

[24]  Weiying Zhou,et al.  UC Office of the President Recent Work Title De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer , 2012 .

[25]  Mark T. W. Ebbert,et al.  Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.

[26]  M. Zavolan,et al.  A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins , 2011, Nature Methods.

[27]  Brigitte Rack,et al.  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.

[28]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[29]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[30]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[31]  N. Slonim,et al.  A universal framework for regulatory element discovery across all genomes and data types. , 2007, Molecular cell.

[32]  W. Gerald,et al.  EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations , 2005, Modern Pathology.

[33]  R. Ren,et al.  Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia , 2005, Nature Reviews Cancer.

[34]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[35]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[36]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[37]  Søren Colda,et al.  Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer , 2014 .

[38]  P. Prandoni,et al.  A Case-Control Study , 2022 .